Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro

被引:5
作者
Holle, JU
Williams, JM
Harper, L
Savage, COS
Taylor, CM [1 ]
机构
[1] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[2] Univ Birmingham, Sch Med, Dept Renal Immunobiol, Birmingham B15 2TT, W Midlands, England
关键词
verocytotoxin (Shiga-like toxin); neutrophils; priming; superoxide; elastase; chemotaxis; protein synthesis inhibition;
D O I
10.1007/s00467-005-1945-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neutrophil activation occurs in diarrhoea-associated HUS and correlates with disease severity, implying a role in pathogenesis. Verocytotoxin (Shiga-like toxin) has been shown to stimulate endothelium to release chemokines and express leukocyte adhesion molecules that would lead to indirect neutrophil-endothelial interaction. A direct action of verocytotoxin (VT) on neutrophils has been proposed, although in vitro studies of this are controversial. In this report we examine the effect of verocytotoxin-1 (Shiga-like toxin-1) (VT1) and verocytotoxin-2 (VT2) on human neutrophils in vitro with regard to priming, the release of superoxide and elastase, and chemotaxis. Neutrophils were incubated with VT1 or VT2 and superoxide and elastase release was measured over 120 and 45 minutes respectively. Priming was investigated by pre-treating the neutrophils with VT1 or VT2, exposing them to formyl-met-leu-phe (fMLP) or phorbol myristic acid (PMA) and measuring superoxide release. Neutrophil chemotaxis towards fMLP was assessed with and without pre-incubation with VT1 and VT2. We found that neither of the toxins induced superoxide or elastase release. Priming with VT1 significantly reduced superoxide release when neutrophils were stimulated with fMLP or PMA. VT2 priming gave a reduced superoxide release with PMA but not fMLP. Heat-inactivation of the toxins gave similar results. Pre-treatment of neutrophils with VT1 or VT2 did not affect chemotaxis towards fMLP after a 2-hour incubation period. In conclusion, VT1 and VT2 do not activate primed neutrophils in vitro. Nor do they affect chemotaxis towards fMLP. They may impair neutrophil priming.
引用
收藏
页码:1237 / 1244
页数:8
相关论文
共 36 条
[1]   Effect of Shiga toxins on granulocyte function [J].
Aoki, Y ;
Takeda, T .
MICROBIAL PATHOGENESIS, 2002, 32 (06) :279-285
[2]   PRIMING OF HUMAN NEUTROPHIL FUNCTIONS BY TUMOR-NECROSIS-FACTOR - ENHANCEMENT OF SUPEROXIDE ANION GENERATION, DEGRANULATION, AND CHEMOTAXIS TO CHEMOATTRACTANTS C5A AND F-MET-LEU-PHE [J].
BAJAJ, MS ;
KEW, RR ;
WEBSTER, RO ;
HYERS, TM .
INFLAMMATION, 1992, 16 (03) :241-250
[3]   EVIDENCE THAT VEROTOXINS (SHIGA-LIKE TOXINS) FROM ESCHERICHIA-COLI BIND TO P-BLOOD-GROUP ANTIGENS OF HUMAN ERYTHROCYTES IN-VITRO [J].
BITZAN, M ;
RICHARDSON, S ;
HUANG, C ;
BOYD, B ;
PETRIC, M ;
KARMALI, MA .
INFECTION AND IMMUNITY, 1994, 62 (08) :3337-3347
[4]   Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome [J].
Chandler, WL ;
Jelacic, S ;
Boster, DR ;
Ciol, MA ;
Williams, GD ;
Watkins, SL ;
Igarashi, T ;
Tarr, PI .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01) :23-32
[5]   Priming differentially regulates neutrophil adhesion molecule expression/function [J].
Condliffe, AM ;
Chilvers, ER ;
Haslett, C ;
Dransfield, I .
IMMUNOLOGY, 1996, 89 (01) :105-111
[6]  
Cooling LLW, 1998, INFECT IMMUN, V66, P4355
[7]  
CUTLER JE, 1974, P SOC EXP BIOL MED, V147, P471
[8]   Shigatoxin-1 binding and receptor expression in human kidneys do not change with age [J].
Ergonul, Z ;
Clayton, F ;
Fogo, AB ;
Kohan, DE .
PEDIATRIC NEPHROLOGY, 2003, 18 (03) :246-253
[9]   NEUTROPHIL ACTIVATION IN THE HEMOLYTIC UREMIC SYNDROME - FREE AND COMPLEXED ELASTASE IN PLASMA [J].
FITZPATRICK, MM ;
SHAH, V ;
FILLER, G ;
DILLON, MJ ;
BARRATT, TM .
PEDIATRIC NEPHROLOGY, 1992, 6 (01) :50-53
[10]  
FITZPATRICK MM, 1992, KIDNEY INT, V42, P952